BioElectronics Corporation announced its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx® device into Mexico.e Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx® in Mexico. It is expected that they will receive their initial stocking order during the second quarter, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -33.33% | -50.00% | -50.00% |
03-25 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
02-23 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 2.47M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- BIEL Stock
- News BioElectronics Corporation
- BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico